Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 1, 2006, Pages 127-130

  Perni, Sriram C ^a   Predanic, Mladen ^a   Kalish, Robin B ^a   Chervenak, Frank A ^a   Chasen, Stephen T ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Down syndrome; First trimester screening; Trisomy 18; Trisomy 21

Indexed keywords

ADULT; ALGORITHM; ANEUPLOIDY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROWN RUMP LENGTH; ETHNOLOGY; FALSE POSITIVE RESULT; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; GONADOTROPIN BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL SOCIETY; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SAMPLE SIZE; STANDARDIZATION; TRISOMY 18; TRISOMY 21; UNITED STATES;

ANEUPLOIDY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOMES, HUMAN, PAIR 18; CLINICAL TRIALS; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GENETIC SCREENING; HUMANS; INCIDENCE; MATERNAL AGE; NECK; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; TRISOMY; ULTRASONOGRAPHY, PRENATAL; UNITED STATES;

EID: 29544437559     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.06.068     Document Type: Article

References (19)

1. R.J. Snijders, P. Noble, N. Sebire, A. Souka, and K.H. Nicolaides U.K. multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation Lancet 352 1998 343 346
2. A. Tabor, J. Philip, M. Madsen, J. Bang, E.B. Obel, and B. Norgaard-Pedersen Randomised controlled trial of genetic amniocentesis in 4606 low-risk women Lancet 1 1986 1287 1293
3. D. Bettelheim, B. Kolinek, A. Schaller, and G. Bernaschek Complication rates of invasive intrauterine procedures in a centre for prenatal diagnosis and therapy Ultraschall Med 23 2002 119 122
4. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-887.
5. N.J. Wald, W.J. Huttly, and A.K. Hackshaw Antenatal screening for Down's syndrome with a quadruple test Lancet 361 2003 835 836
6. J.E. Haddow, G.E. Palomaki, G.J. Knight, J. Williams, W.A. Miller, and A. Johnson Screening of maternal serum for fetal Down's syndrome in the first trimester N Engl J Med 338 1998 955 961
7. D.A. Krantz, J.W. Larsen, P.D. Buchanan, and J.N. Macri First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A Am J Obstet Gynecol 174 1996 612 616
8. R. Wapner, E. Thom, J.L. Simpson, E. Pergament, R. Silver, and K. Filkins First-trimester screening for trisomies 21 and 18 N Engl J Med 349 2003 1405 1413
9. R. Bindra, V. Heath, A. Liao, K. Spencer, and K.H. Nicolaides One-step clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15030 pregnancies Ultrasound Obstet Gynecol 20 2002 219 225
10. K. Spencer, V. Souter, N. Tul, R. Snijders, and K.H. Nicolaides A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A Ultrasound Obstet Gynecol 13 1999 231 237
11. F.D. Malone, and M.E. D'Alton Society for Maternal-Fetal Medicine. First-trimester sonographic screening for Down syndrome Obstet Gynecol 102 2003 1066 1079
12. F.D. Malone, N.J. Wald, J.A. Canick, R.H. Ball, D.A. Nyberg, and C.H. Comstock First- and second-trimester evaluation of risk (FASTER) trial: principal results of the NICHD multicenter Down syndrome screening study Am J Obstet Gynecol 189 2003 S56
13. M.T. Mennuti, and D.A. Driscoll Screening for Down's syndrome N Engl J Med 349 2004 1471 1473
14. S.T. Chasen, G. Sharma, R.B. Kalish, and F.A. Chervenak First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population Ultrasound Obstet Gynecol 22 2003 149 151
15. D.A. Krantz, T.W. Hallahan, F. Orlandi, P. Buchanan, J.W. Larsen, and J.N. Macri First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency Obstet Gynecol 96 2000 207 213
16. J.N. Macri, R.W. Anderson, D.A. Krantz, J.W. Larsen, and P.D. Buchanan Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome Am J Obstet Gynecol 174 1996 566 572
17. G. Monni, M.A. Zoppi, R.M. Ibba, and M. Floris Results of measurement of nuchal translucency before and after training Lancet 350 1997 1631
18. K.H. Nicolaides Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities Am J Obstet Gynecol 191 2004 45 67
19. K. Spencer, D.A. Aitken, and J.A. Crossley Maternal serum total hCG and free beta-hCG in the first trimester from trisomy 21 pregnancies Prenat Diagn 20 2000 770 771